Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID‐19 endemicity
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.29285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Jinyoung Yang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Korea Disease Control and Prevention Agency, Samsung Medical Center, Korea National Institute of Health.
Abstract (Originalsprache)
Despite a high vaccination rate, the COVID‐19 pandemic continues with immune‐evading Omicron variants. The success of additional antigenic stimulation through breakthrough infection (BI) and updated vaccination in overcoming antigenic imprinting needs to be determined. Participants in a long‐term follow‐up cohort of healthcare worker (HCW) vaccinee were categorized according to their infection/vaccination status. Anti‐SARS‐CoV‐2 spike/nucleocapsid protein antibodies were measured, and plaque reduction neutralization tests (PRNTs) against wild‐type (WT), BA.5, BN.1, and XBB.1.5 were conducted. The neutralization activity of intravenous immunoglobulin (IVIG) products was evaluated to assess the immune status of the general population. Ninety‐five HCWs were evaluated and categorized into seven groups. The WT PRNT ND 50 value was highest regardless of infection/vaccination status, and groups with recent antigenic stimulation showed high PRNT titers overall. Groups with double Omicron stimulation, either by BI plus BA.4/5 bivalent vaccination or repeated BI, exhibited significantly higher BA.5 and BN.1 PRNT to WT PRNT ratios than those with single Omicron stimulation. Overall group immunity was estimated to be boosted in January 2023, reflecting the effect of the BA.4/5 bivalent booster and additional BIs, but slightly declined in June 2023. A substantial increase in the antibody concentrations of IVIG products was noticed in 2022, and recently produced IVIG products exhibited a substantial level of cross‐reactive neutralizing activity against emerging variants. Neutralizing activity against emerging variants could be enhanced by repeated antigenic stimulation via BI and/or updated vaccination. Overall group immunity was elevated accordingly, and IVIG products showed substantial activity against circulating strains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Center for Vaccine Research, National Institute of Infectious Diseases, Korea National Institute of Health, Cheongju, Republic of Korea.
- Center for Emerging Virus Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
- Asia Pacific Foundation for Infectious Diseases (APFID), Seoul, Republic of Korea.
ORCID-Profile: Jinyoung Yang, Hye-Jin Kim, Jun-Won Kim, Jin Yang Baek, Young Jae Lee, Ju-Yeon Choi, Su-Hwan Kim, Hyeonji Jeong, Eun Joo Chung, Gi-Eun Rhie, Byoung Kwon Park, So-Young Lee, Kyong Ran Peck, Byoungguk Kim, Jae-Hoon Ko
Förderung
- Korea Disease Control and Prevention Agency
- Samsung Medical Center
- Korea National Institute of Health
Zitieren
APA
Yang, J., Kim, H. J., Kim, J. W., Baek, J. Y., Lee, Y. J., Choi, J. Y., Kim, S. H., Jeong, H., Chung, E. J., Rhie, G. E., Park, B. K., Lee, S. Y., Peck, K. R., Kim, B., & Ko, J. H. (2023). Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID‐19 endemicity. Journal of Medical Virology. https://doi.org/10.1002/jmv.29285
Vancouver
Yang J, Kim HJ, Kim JW, Baek JY, Lee YJ, Choi JY, et al. Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID‐19 endemicity. Journal of Medical Virology. 2023. doi:10.1002/jmv.29285
BibTeX
@article{Yang2023,
author = {Yang, Jinyoung and Kim, Hye-Jin and Kim, Jun-Won and Baek, Jin Yang and Lee, Young Jae and Choi, Ju-Yeon and Kim, Su-Hwan and Jeong, Hyeonji and Chung, Eun Joo and Rhie, Gi-Eun and Park, Byoung Kwon and Lee, So-Young and Peck, Kyong Ran and Kim, Byoungguk and Ko, Jae-Hoon},
title = {Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID‐19 endemicity},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.29285}
}
EUVIMED